自适应伺服通气对心力衰竭患者心脏交感神经功能的早期治疗效应:联合11C-HED PET与123I-MIBG SPECT评估
本研究在9例心力衰竭患者中于自适应伺服通气(ASV)治疗前及治疗6个月后评估疗效,采用超声心动图、多导睡眠监测、生物标志物、11C-羟基麻黄碱(HED)PET及平面123I-间碘苄胍(MIBG)显像评价交感神经功能。ASV降低呼吸暂停低通气指数并改善血浆脑钠肽浓度,123I-MIBG早期心/纵隔比值升高,11C-HED全局滞留指数改善,提示ASV可能在治疗6个月后初期改善突触前心脏交感神经功能。
要点
- ASV治疗6个月后呼吸暂停低通气指数降低,血浆脑钠肽浓度改善。
- 123I-MIBG早期心/纵隔比值由2.19±0.58升至2.40±0.67(P=0.045)。
- 11C-HED全局滞留指数由0.068±0.033/s升至0.075±0.034/s(P=0.029)。
核心结论
- ASV降低呼吸暂停低通气指数并改善脑钠肽,可能在治疗6个月后初期改善心力衰竭患者突触前心脏交感神经功能。
研究设计与样本
- 研究纳入9例心力衰竭患者,年龄57.3±17.3岁,左心室射血分数36.1±16.7%,于ASV治疗前及治疗6个月后评估疗效。
- 评估手段包括超声心动图、多导睡眠监测、生物标志物、11C-HED PET(突触前功能标志物)及平面123I-MIBG显像(计算洗脱率)。
主要发现
- ASV治疗降低呼吸暂停低通气指数并改善血浆脑钠肽浓度。
- 123I-MIBG早期心/纵隔比值在ASV治疗后升高(2.19±0.58升至2.40±0.67;P=0.045)。
- 123I-MIBG洗脱率未变化(23.8±7.3%至23.8±8.8%;P=0.122)。
- 11C-HED全局滞留指数由0.068±0.033/s改善至0.075±0.034/s(P=0.029)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Adaptive servo-ventilation (ASV), a novel respiratory support therapy for sleep disorders, may improve cardiac function in heart failure (HF). However, the reasons that ASV improves cardiac function have not been fully studied especially in sympathetic nervous function (SNF). The purpose of the present study was to investigate the effects of ASV therapy on cardiac SNF in patients with HF. METHODS: We evaluated ASV therapeutic effects before and 6 months after ASV therapy in 9 HF patients [57.3 ± 17.3 years old, left ventricular ejection fraction (LVEF) 36.1 ± 16.7%]. We performed echocardiography, polysomnography, biomarkers, 11C-hydroxyephedrine (HED) PET as a presynaptic function marker and planar 123I-metaiodobenzylguanidine (MIBG) to evaluate washout rate. RESULTS: ASV therapy reduced apnea-hypopnea index (AHI) and improved plasma brain natriuretic peptide (BNP) concentration. In 123I-MIBG imaging, the early heart/mediastinum (H/M) ratio increased after ASV therapy (2.19 ± 0.58 to 2.40 ± 0.67; P = 0.045). Washout rate did not change (23.8 ± 7.3% to 23.8 ± 8.8%; P = 0.122). Global 11C-HED retention index (RI) improved from 0.068 ± 0.033/s to 0.075 ± 0.034/s (P = 0.029). CONCLUSIONS: ASV reduced AHI and improved BNP. ASV might initially improve presynaptic cardiac sympathetic nervous function in HF patients after 6 months of treatment.
引用
- Tokuda Y, Sakakibara M, Yoshinaga K, et al. Early therapeutic effects of adaptive servo-ventilation on cardiac sympathetic nervous function in patients with heart failure evaluated using a combination of 11C-HED PET and 123I-MIBG SPECT. J Nucl Cardiol. 2017. PMID: 29181786. doi:10.1007/s12350-017-1132-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。